Escalation, group and A + B designs for dose-finding trials.

Area of Science:

• Biostatistics
• Clinical Trial Design

Background:

• Dose-finding trials are crucial for determining optimal drug dosages.
• Existing designs may not adequately address ordinal toxicity outcomes.

Purpose of the Study:

• To provide construction rules for escalation, A+B, and group dose-finding designs.
• To analyze and compare the operational characteristics of these designs via simulation.
• To consider dose-finding designs specifically for trials with ordinal toxicity outcomes.

Main Methods:

• Development of rules for constructing escalation, A+B, and group designs.
• Simulation studies to evaluate design performance.
• Focus on designs applicable to ordinal toxicity data.

Main Results:

• Established rules for constructing various dose-finding designs.
• Comparative analysis of design characteristics through simulations.
• Consideration of designs suitable for ordinal toxicity data.

Conclusions:

• The paper offers a methodological framework for dose-finding trial design construction.
• Simulation results provide insights into the comparative performance of different designs.
• The work addresses the need for specialized designs in trials with ordinal toxicity outcomes.